# Oral Bifidobacterium Longum for Skin Barrier Dysfunction in Obesity

> **NCT07184905** · NA · COMPLETED · sponsor: **Shenzhen People's Hospital** · enrollment: 140 (actual)

## Conditions studied

- Skin Barrier to Water Loss
- Microbial Colonization

## Interventions

- **BIOLOGICAL:** Oral administration of inactive Bifidobacterium longum group
- **BIOLOGICAL:** Oral Bifidobacterium longum group

## Key facts

- **NCT ID:** NCT07184905
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-09
- **Primary completion:** 2025-10-27
- **Final completion:** 2025-10-31
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2025-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07184905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07184905, "Oral Bifidobacterium Longum for Skin Barrier Dysfunction in Obesity". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07184905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*